Emmaus Life Sciences, Inc. Annual report pursuant to Section 13 and 15(d)

SELECTED FINANCIAL STATEMENT CAPTIONS - ASSETS

12 Months Ended

Dec. 31, 2020

NOTE 4—SELECTED FINANCIAL STATEMENT CAPTIONS - ASSETS

Inventories consisted of the following (in thousand):

	As of December 31,
	2020			2019
Raw materials and components	$	1,486		$	1,187
Work-in-process		721			1,629
Finished goods		6,064			5,204
Inventory reserve		(1,184	)		(49	)
Total	$	7,087		$	7,971

Prepaid expenses and other current assets consisted of the following (in thousands):

	As of December 31,
	2020		2019
Other prepaid expenses and current assets		1,097		667
Prepaid insurance	$	388	$	735
Total	$	1,485	$	1,402

Property and equipment consisted of the following (in thousands):

	As of December 31,
	2020			2019
Equipment	$	347		$	335
Leasehold improvements		39			77
Furniture and fixtures		99			95
Total property and equipment		485			507
Less: accumulated depreciation		(365	)		(356	)
Property and Equipment, net	$	120		$	151

For the years ended December 31, 2020 and 2019, depreciation expense was approximately $46,000 and $47,000, respectively.